Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas

PURPOSE: Numerous preclinical studies demonstrate that angiogenesis inhibitors can increase the efficacy of radiation therapy (RT). We sought to examine safety and efficacy of bevacizumab (BV) and RT in soft tissue sarcomas (STS) and explore biomarkers for treatment response. METHODS AND MATERIALS:...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Yoon, Sam S., Duda, Dan G., Karl, Daniel L., Kim, Tae-Min, Kambadakone, Avinash R., Chen, Yen-Lin, Rothrock, Courtney, Rosenberg, Andrew E., Nielsen, G. Petur, Kirsch, David G., Choy, Edwin, Harmon, David C, Hornicek, Francis J., Dreyfuss, Jonathan, Ancukiewicz, Marek, Sahani, Dushyant V., Park, Peter J., Jain, Rakesh K., DeLaney, Thomas F.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021107/
https://ncbi.nlm.nih.gov/pubmed/20932656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.07.024
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg